Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
Document › Details

Bayer AG. (5/28/14). "Press Release: Andreas Fibig to Leave Bayer HealthCare Pharmaceuticals". Leverkusen.

Organisation Organisation Bayer HealthCare Pharmaceuticals Inc.
  Group Bayer (Group)
Products Product pharmaceutical
  Product 2 fragrance
Persons Person Fibig, Andreas (IFF 201409– CEO before Bayer HealthCare Pharma + Pfizer + P&U + Boehringer Ingelheim)
  Person 2 Brandicourt, Olivier (Sanofi 201508 CEO before CEO of Bayer HealthCare before Pfizer Inc)

Andreas Fibig (52), President of Bayer HealthCare Pharmaceuticals and a member of the Bayer HealthCare Executive Committee, will leave Bayer HealthCare to become Chief Executive Officer of International Flavors & Fragrances Inc., New York, NY, USA, effective September 1, 2014.

"With his experience and his commitment, Andreas Fibig has advanced the very positive development of our Pharmaceuticals business over the past years making it to one of the fastest growing pharmaceutical companies in the industry," said Olivier Brandicourt, CEO of Bayer HealthCare. "We thank him and wish him all the best for his next step in his career and his future."

The company will announce a successor for Andreas Fibig in a few days.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.9 billion (2013), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56,000 employees (Dec 31, 2013) and is represented in more than 100 countries. More information is available at

Our online press service is just a click away:
Follow us on Facebook:
Follow us on Twitter:

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Record changed: 2017-04-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Bayer (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top